Author:
Kapetas Asha J,Abuhelwa Ahmad Y,Sorich Michael J,McKinnon Ross A,Rodrigues A David,Rowland Andrew,Hopkins Ashley M
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Wilkinson GR. Drug metabolism and variability among patients in drug response. The New England journal of medicine. 2005;352(21):2211–21.
2. Yan Z, Caldwell GW. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery. Current topics in medicinal chemistry. 2001;1(5):403–25.
3. Waring MJ, Arrowsmith J, Leach AR, Leeson PD, Mandrell S, Owen RM, Pairaudeau G, Pennie WD, Pickett SD, Wang J, Wallace O, Weir A. An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nature Reviews Drug Discovery. 2015;14(7):475–86.
4. FDA. Clinical drug interaction studies—cytochrome P450 enzyme- and transporter-mediated drug interactions guidance for industry. 2020.
5. EMA. Guideline on the investigation of drug interactions. 2012.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献